Sebacia
2905 Premiere Parkway, Suite 150
Duluth
Georgia
30097
United States
Tel: 888-935-4411
Website: http://www.sebacia.com/
Email: info@sebacia.com
9 articles with Sebacia
-
Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months
10/11/2018
Oral presentation today at ASDS Annual Meeting by leading dermatologist Ashish Bhatia, MD
-
Sebacia Highlights Oral Presentation of EU Real-World Pre-Conditioning Study Results at ASDS Annual Meeting 2018
10/8/2018
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that results from its real-world pre-conditioning study in Europe evaluating Sebacia Microparticles for treatment of facial acne has been accepted for an oral presentation
-
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
9/17/2018
U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019
-
Sebacia Announces Presentation of Data Demonstrating Sebacia Microparticles as an Effective Contrast Enhancing Agent for Potential Use in Evaluating Dermatologic Conditions
4/9/2018
Sebacia, Inc. will present data showing Sebacia Microparticles could help improve dermatologic imaging by acting as a contrast enhancing agent.
-
Sebacia Announces $36 Million Equity And Debt Financing To Advance Breakthrough In-Office Procedure For Acne
7/25/2017
-
Sebacia Announces Completion Of Enrollment In Pivotal U.S. Clinical Trial For Severe Acne
10/7/2015
-
Sebacia Announces Series C Financing To Advance Innovative Dermatology Treatment For Acne
6/25/2015
-
Sebacia Announces New Vice President, Engineering And Program Management
6/25/2015
-
Sebacia Release: Study Points Way To New Treatment Procedure For Acne
3/20/2015